A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosis.
Mathew T, Kamath V, John SK, Netravathi M, Iyer RB, Raghavendra S, Kumar S, Neeharika ML, Gupta S, Murgod U, Shivakumar R, Annadure RK, Ichaporia N, Rohatgi A, Nair SS, Yareeda S, Anand B, Singh P, Renukaradhya U, Arulselvan V, Reddy YM, Surya N, Sarma GRK, Nadig R, Deepalam S, Sharath Kumar GG, Satishchandra P, Singhal BS, Parry G.
Mathew T, et al. Among authors: rohatgi a.
Mult Scler Relat Disord. 2022 Oct;66:104059. doi: 10.1016/j.msard.2022.104059. Epub 2022 Jul 25.
Mult Scler Relat Disord. 2022.
PMID: 35908446